Diabetes

Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.

An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.

Kidney disease occurs along a continuum, and for people who have diabetes, the risk of developing kidney disease is significantly elevated.

For health care providers, staying up to date on drug development trends is crucial to understanding the implications of these therapies and how they can best help their patients.

LifePlus has announced their product Lifeleaf, which is an noninvasive monitor for glucose, blood pressure, heart rate, respiration rate, and oxygen saturation. How can change the field of wearables?

Sanofi announced that the FDA has accepted the New Drug Application (NDA) for Zynquista (sotagliflozin).

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Population-based screening was found to be associated with a reduction in admissions, physician visits, and prescribed medication for individuals diagnosed with type 2 diabetes.

CVS Health's Chief Medical Officer Troyen A. Brennan, MD, outlined how the combination of data-driven insights, and the convenience of community-based retail health care can provide a highly personalized health care experience that supports the primary care medical home, and can improve patient outcomes and lower costs.

Patients with diabetes taking canagliflozin achieved better glycemic control, were less likely to stop taking the medication, and were less likely to switch to another drug.

Upgrades to the insulin pen to improve disease management and prevent hypoglycemia due to overdoses are on the horizon.

In an additional analysis from the CANVAS program, new data reinforce evidence of improved renal outcomes for those with type 2 diabetes and chronic kidney disease.

One Drop is a company that has a great holistic service using CDE to help patients get their diabetes better controlled, and recent data support their mission.

The health insurer recently launched its Emerging Solutions' platform.

Certified Diabetes Educators (CDEs) can make a tremendous difference in the lives of people who have diabetes.

An artificial pancreas can improve blood sugar control for people with type 1 diabetes (T1D), according to a new study.

Researchers concluded that metformin may reduce risk of nonsevere statin muscle pain.

For its upcoming Directions in Pharmacy® conference in Nashville, Tennessee, Pharmacy Times Continuing EducationTM is partnering with Lilly USA, LLC to present “An Insulin Monotherapy Option for Patients on High Doses of Insulin.”

Officials with the FDA have approved marketing of the first medical device to use artificial intelligence (AI) to detect notable eye disease diabetic retinopathy (DR) in adults with diabetes.

US report indicates new drivers of death have emerged over time and have continued to unequally affect residents at the state level.

Sanofi plans to offer a discount for some patients with diabetes who are uninsured or who have high-deductible insurance plans.

Smart socks, such as those from Siren, seek to help identify infections, and ulcers before they happen, but the data is lacking. Are they worth it?

Exenatide extended-release (Bydureon) approved as an add-on therapy to basal insulin in adults with type 2 diabetes with inadequate glycemic control.

Long-term use of dietary supplements may improve C-reactive protein, HDL cholesterol, serum homocysteine, blood pressure, and incidence of diabetes.